ES2103422T3 - Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso. - Google Patents
Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso.Info
- Publication number
- ES2103422T3 ES2103422T3 ES93301010T ES93301010T ES2103422T3 ES 2103422 T3 ES2103422 T3 ES 2103422T3 ES 93301010 T ES93301010 T ES 93301010T ES 93301010 T ES93301010 T ES 93301010T ES 2103422 T3 ES2103422 T3 ES 2103422T3
- Authority
- ES
- Spain
- Prior art keywords
- bilobalide
- infection
- individual
- treat
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA INVENCION PROPORCIONA UN METODO DE TRATAMIENTO DE UNA INFECCION EN UN INDIVIDUO, POR ADMINISTRACION DE UNA DOSIS EFECTIVA DE BILOBALIDO O DE UN DERIVADO ACEPTABLE FARMACOLOGICAMENTE DEL MISMO. LA ACTIVIDAD CONTRA LA INFECCION POR PNEUMOCYSTIS CARINII TIENE PRINCIPAL UTILIDAD EN EL TRATAMIENTO DE INFECCIONES ASOCIADAS CON EL SIDA. EL BILOBALIDO PUEDE SER ADMINISTRADO SISTEMICA O TOPICAMENTE DE ACUERDO CON LA INVENCION. PARA EL USO SISTEMICO, SE PUEDEN USAR LAS RUTAS DE ADMINISTRACION ORAL Y PARENTERAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929202993A GB9202993D0 (en) | 1992-02-13 | 1992-02-13 | Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2103422T3 true ES2103422T3 (es) | 1997-09-16 |
Family
ID=10710286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93301010T Expired - Lifetime ES2103422T3 (es) | 1992-02-13 | 1993-02-12 | Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5264216A (es) |
EP (1) | EP0556051B1 (es) |
JP (1) | JP3156212B2 (es) |
KR (1) | KR100251394B1 (es) |
AT (1) | ATE152911T1 (es) |
CA (1) | CA2089309C (es) |
DE (1) | DE69310565T2 (es) |
DK (1) | DK0556051T3 (es) |
ES (1) | ES2103422T3 (es) |
GB (1) | GB9202993D0 (es) |
GR (1) | GR3023414T3 (es) |
HK (1) | HK1000276A1 (es) |
SG (1) | SG48723A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379714B1 (en) | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
US6036696A (en) | 1997-12-19 | 2000-03-14 | Stryker Technologies Corporation | Guide-pin placement device and method of use |
US20080281330A1 (en) * | 2005-03-17 | 2008-11-13 | Ferrante Joseph M | Medical Securing Member Placement System |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3338995A1 (de) * | 1983-10-27 | 1985-05-09 | Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe | Bilobalid enthaltende arzneimittel |
IT1238684B (it) * | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
-
1992
- 1992-02-13 GB GB929202993A patent/GB9202993D0/en active Pending
- 1992-03-25 US US07/857,220 patent/US5264216A/en not_active Expired - Lifetime
-
1993
- 1993-02-11 CA CA002089309A patent/CA2089309C/en not_active Expired - Fee Related
- 1993-02-12 DE DE69310565T patent/DE69310565T2/de not_active Expired - Fee Related
- 1993-02-12 AT AT93301010T patent/ATE152911T1/de not_active IP Right Cessation
- 1993-02-12 DK DK93301010.0T patent/DK0556051T3/da active
- 1993-02-12 JP JP06239393A patent/JP3156212B2/ja not_active Expired - Fee Related
- 1993-02-12 EP EP93301010A patent/EP0556051B1/en not_active Expired - Lifetime
- 1993-02-12 SG SG1996000629A patent/SG48723A1/en unknown
- 1993-02-12 ES ES93301010T patent/ES2103422T3/es not_active Expired - Lifetime
- 1993-02-13 KR KR1019930002025A patent/KR100251394B1/ko not_active IP Right Cessation
-
1997
- 1997-05-15 GR GR960403639T patent/GR3023414T3/el unknown
- 1997-09-24 HK HK97101825A patent/HK1000276A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0556051B1 (en) | 1997-05-14 |
CA2089309C (en) | 2004-11-30 |
KR930017577A (ko) | 1993-09-20 |
DK0556051T3 (da) | 1997-07-28 |
JPH0624974A (ja) | 1994-02-01 |
JP3156212B2 (ja) | 2001-04-16 |
DE69310565D1 (de) | 1997-06-19 |
CA2089309A1 (en) | 1993-08-14 |
GB9202993D0 (en) | 1992-03-25 |
US5264216A (en) | 1993-11-23 |
HK1000276A1 (en) | 1998-02-20 |
KR100251394B1 (ko) | 2000-05-01 |
DE69310565T2 (de) | 1997-12-18 |
ATE152911T1 (de) | 1997-05-15 |
SG48723A1 (en) | 1998-05-18 |
EP0556051A1 (en) | 1993-08-18 |
GR3023414T3 (en) | 1997-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69214938D1 (de) | Mittel zur topischen verabreichung von arzneiwirkstoffen | |
DK0600079T3 (da) | Oral 1alpha-hydroxyprævitamin D | |
CO5251419A1 (es) | Composiciones nanoparticuladas de eplerenona | |
ES2083668T3 (es) | Combinaciones antiviricas que contienen analogos de nucleosidos. | |
DE69521693D1 (de) | Taxanderivate enthaltende arzneizubereitungen | |
ITRM920270A0 (it) | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. | |
IT1235153B (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento | |
ATE50499T1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
MY108146A (en) | Medicaments for treating inflammatory conditions or for analgesia | |
DE69322251D1 (de) | Medizinische zusammensetzung | |
ITRM910002A1 (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. | |
FR2674754B1 (fr) | Composition medicamenteuse micronisee. | |
IT1256623B (it) | Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche | |
ES2103422T3 (es) | Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso. | |
IT1249650B (it) | N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico | |
ES2072386T3 (es) | Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b. | |
ES2128353T3 (es) | Composicion topica que contiene penciclovir. | |
ATE189395T1 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen | |
ATE145333T1 (de) | Hirudin enthaltende orale arzneimittel | |
IT1249060B (it) | Composizione farmaceutica ad uso topico per il trattamento di cicatrizzazione e riepitelizzazione di ulcere flebostatiche croniche. | |
IT1272762B (it) | Derivati benz/e/indenici farmaceuticamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche | |
ES2135424T3 (es) | Composicion oral a base de ibuprofeno. | |
ITMI931598A1 (it) | Uso terapeutico della fosfocreatina | |
ES2114681T3 (es) | Tratamiento transdermico de cancer con camptotecina insoluble en agua en la forma de anillo de lactona cerrado. | |
YU49496B (sh) | 2,4-disulfofenil butil nitron, njegove soli, i njihova primena kao farmaceutskih kompozicija |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 556051 Country of ref document: ES |